Worsening of respiratory status during neutropenia recovery in noncritically ill hematological patients: results of a prospective multicenter study

Respiration. 2015;90(3):229-34. doi: 10.1159/000433556. Epub 2015 Jul 31.

Abstract

Background: Neutropenia recovery (NR) has been associated with worsening preexisting lung injury in up to 50% of critically ill cancer patients. However, only limited relevant data exist in the general population of hematological patients.

Objectives: To assess the incidence of acute respiratory deterioration during NR in patients with hematological malignancies.

Methods: Adult patients with neutropenia expected to last more than 7 days were included. Worsening of respiratory status (WRS) was defined as a decrease in oxygen saturation of ≥5%, the need for oxygen therapy for ≥24 h, an increase in oxygen flow of ≥50% in patients previously treated with oxygen, or the need for mechanical ventilation. NR was defined as the 3 days preceding or following a neutrophil count of >0.5 × 109/l.

Results: A total of 16 of 50 patients included in this pilot study experienced WRS during NR (32%), and 13 patients had WRS during neutropenia (26%). The incidence density of WRS was 0.53 (±0.79) episodes per 10 days during NR and 0.20 (±0.39) episodes per 10 days during neutropenia (p = 0.004). Sepsis, stem cell transplantation, preexisting pneumonia, or the use of granulocyte colony-stimulating factor were not associated with WRS during NR.

Conclusion: Up to one third of noncritically ill hematological patients with expected neutropenia of more than 7 days experience WRS during NR. Clinical consequences and risk factors for WRS during NR remain to be evaluated.

MeSH terms

  • Acute Lung Injury / etiology*
  • Acute Lung Injury / physiopathology
  • Adult
  • Aged
  • Cohort Studies
  • Confidence Intervals
  • Disease Progression
  • Female
  • Follow-Up Studies
  • France
  • Granulocyte Colony-Stimulating Factor / administration & dosage*
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Hematologic Neoplasms / drug therapy*
  • Hematologic Neoplasms / pathology
  • Hematologic Neoplasms / surgery*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Male
  • Middle Aged
  • Neutropenia / physiopathology*
  • Odds Ratio
  • Pilot Projects
  • Prospective Studies
  • Recovery of Function
  • Risk Assessment
  • Severity of Illness Index
  • Time Factors

Substances

  • Granulocyte Colony-Stimulating Factor